This article was originally published in The Gray Sheet
FDA's device center will hold public meeting Sept. 20-22 at the Sheraton in Reston, Virginia to begin the process of developing standards required by the Mammography Quality Standards Act of 1992. The meeting will include presentations by FDA and breakout sessions to gain public input on the implementation of MQSA. FDA reported plans for the meeting earlier this year ("The Gray Sheet" May 10, I&W-4)....
You may also be interested in...
Operation Warp Speed will hold back initial shipments to ensure two-dose regimens can be completed; 15 December is ‘chalk’ target date for emergency authorization of Pfizer vaccine, OWS’ Gustave Perna says, calling it only a projection that does not impinge on FDA authority. Sending only half shipments also eases burden on cold shortage capacity at state and local level, he says.
CMS acknowledges stakeholders may need more details about the plan before it is finalized and a delay will give the agency more time to ‘consider the issue.’
Private Company Edition: Venture capital financings didn’t take a break during Thanksgiving week. In addition to the $800m Resilience raised to fund manufacturing services, SomaLogic closed a $121m series A round to fund its proteomic tools for drug discovery and diagnostics development.